U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C10H12N2O
Molecular Weight 176.2151
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of Serotonin

SMILES

NCCC1=CNC2=CC=C(O)C=C12

InChI

InChIKey=QZAYGJVTTNCVMB-UHFFFAOYSA-N
InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2

HIDE SMILES / InChI

Molecular Formula C10H12N2O
Molecular Weight 176.2151
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Serotonin (5-hydroxytryptamine, or 5-HT) is a monoamine neurotransmitter produced by serotonergic neurons in the CNS and enterochromaffin cells in the gastrointestinal tract. Pharmacologic action of serotonin is mediated by a large and diverse range of 5-HT receptors. Serotonin plays an important part in the biochemistry of depression, migraine, bipolar disorder, and anxiety. It is also believed to be influential on sexuality and appetite. Creatinine is a product of the metabolic breakdown of creatine phosphate in muscle. Creatinine is filtered by healthy kidneys. Serotonin creatinine sulfate complex was the first isolated salt form of serotonin.

Approval Year

PubMed

PubMed

TitleDatePubMed
Functional reconstitution and characterization of recombinant human alpha 1-glycine receptors.
2001-06-15
Pharmacological characterization of the rat paw edema induced by Bothrops lanceolatus (Fer de lance) venom.
2001-06
Interaction of serotonin 5-hydroxytryptamine type 2C receptors with PDZ10 of the multi-PDZ domain protein MUPP1.
2001-04-20
Conversion of the ion selectivity of the 5-HT(3a) receptor from cationic to anionic reveals a conserved feature of the ligand-gated ion channel superfamily.
2001-04-06
Peripheral interleukin-6 administration increases extracellular concentrations of serotonin and the evoked release of serotonin in the rat striatum.
2001-04
Substrate and inhibitor specificities for human monoamine oxidase A and B are influenced by a single amino acid.
2001-03-30
Presynaptic neuronal antigens expressed by a small cell lung carcinoma cell line.
2001-02-01
Identification of the aromatic L-amino acid decarboxylase (AADC) gene and its expression in the attachment and metamorphosis of the barnacle, Balanus amphitrite.
2001-02
New avenues in treatment of paediatric migraine: a review of the literature.
2001-02
Evidence for a serotonin transporter deficit in experimental acute liver failure.
2001-02
Human platelet calcium mobilisation in response to beta-amyloid (25-35): buffer dependency and unchanged response in Alzheimer's disease.
2001-02
Distribution and chemical coding of orphanin FQ/nociceptin-immunoreactive neurons in the myenteric plexus of guinea pig intestines and sphincter of Oddi.
2001-01-29
Mapping of 5-HT2A receptors and their mRNA in monkey brain: [3H]MDL100,907 autoradiography and in situ hybridization studies.
2001-01-22
Brain function in a patient with torture related post-traumatic stress disorder before and after fluoxetine treatment: a positron emission tomography provocation study.
2001-01-12
Phenyl benzenesulfonamides are novel and selective 5-HT6 antagonists: identification of N-(2,5-dibromo-3-fluorophenyl)-4-methoxy-3-piperazin-1-ylbenzenesulfonamide (SB-357134).
2001-01-08
Inhibition of evoked glutamate release by the neuroprotective 5-HT(1A) receptor agonist BAY x 3702 in vitro and in vivo.
2001-01-05
M100,907, a selective 5-HT(2A) antagonist, attenuates dopamine release in the rat medial prefrontal cortex.
2001-01-05
Alcohol-induced euphoria: exclusion of serotonin.
2001-01-05
Functional effects of corticosterone on 5-HT(1A) and 5-HT(1B) receptor activity in rat brain: in vivo microdialysis studies.
2001-01-05
Alternating rhythmic activity induced by dorsal root stimulation in the neonatal rat spinal cord in vitro.
2001-01-01
Necessity of thromboxane A2 for initiation of platelet-mediated contact sensitivity: dual activation of platelets and vascular endothelial cells.
2001-01-01
Cisapride and dexamethasone in the prevention of delayed emesis after cisplatin administration.
2001-01
Atrial arrhythmia in a woman treated with fluoxetine: is there a causal relationship?
2001-01
Radiosynthesis of [123I]betaCIT, a selective ligand for the study of the dopaminergic and serotoninergic systems in human brain.
2001-01
Trimethoprim-sulfamethoxazole and clozapine.
2001-01
Misdiagnosis of schizophrenia for a patient with epilepsy.
2001-01
Antisocial personality - part II.
2001-01
Changes of biogenic amine levels in haemolymph during diapausing and non-diapausing status in Pieris brassicae L.
2001-01
Chronic endothelial dysfunction after oversized coronary balloon angioplasty in pigs: a 12-week follow-up of coronary vasoreactivity in vivo and in vitro.
2001-01
Levels of serotonin receptor 2A higher in suicide victims?
2001-01
Paroxetine in breast milk.
2001-01
A novel augmentation strategy for treating resistant major depression.
2001-01
The effect of paroxetine on 5-HT(2A) receptors in depression: an [(18)F]setoperone PET imaging study.
2001-01
Depression among pregnant adolescents: an integrated treatment approach.
2001-01
Ondansetron hydrochloride for the treatment of delirium after coronary artery surgery.
2001-01
Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants?
2001-01
Role of dorsal raphe neurons in paradoxical sleep generation in the cat: no evidence for a serotonergic mechanism.
2001-01
Prevention of galanin upregulation following neonatal infraorbital nerve transection or attenuation of axoplasmic transport does not rescue central vibrissae-related patterns in the rat.
2001-01
Selective loss of Sertoli cell and germ cell function leads to a disruption in sertoli cell-germ cell communication during aging in the Brown Norway rat.
2001-01
Ondansetron is no more effective than supplemental intraoperative oxygen for prevention of postoperative nausea and vomiting.
2001-01
Effects of PKC isozyme inhibitors on constrictor responses in the feline pulmonary vascular bed.
2001-01
Hypothesized treatment for migraines using low doses of tryptophan, niacin, calcium, caffeine, and acetylsalicylic acid.
2001-01
The antidepressant-sensitive dopamine transporter in Drosophila melanogaster: a primordial carrier for catecholamines.
2001-01
ANP, BNP, and CNP enhance bradycardic responses to cardiopulmonary chemoreceptor activation in conscious sheep.
2001-01
Effect of inhibition of MAO and COMT on intrarenal dopamine and serotonin and on renal function.
2001-01
A single serotonergic modulatory cell can mediate reinforcement in the withdrawal network of the terrestrial snail.
2001-01
Melatonin potentiates contractile responses to serotonin in isolated porcine coronary arteries.
2001-01
Vasoactive intestinal peptide: cardiovascular effects.
2001-01
New abortive agents for the treatment of migraine.
2001
A clinical trial on a plate? The potential of 384-well format solid phase extraction for high-throughput bioanalysis using liquid chromatography/tandem mass spectrometry.
2001
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 17:52:43 GMT 2025
Edited
by admin
on Mon Mar 31 17:52:43 GMT 2025
Record UNII
333DO1RDJY
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
ENTERAMINE
Preferred Name English
Serotonin
MART.   MI   WHO-DD  
Common Name English
THROMBOTONIN
Common Name English
SEROTONIN [MI]
Common Name English
3-(2-AMINOETHYL)-1H-INDOL-5-OL
Systematic Name English
5-HYDROXYTRYPTAMINE
Systematic Name English
Serotonin [WHO-DD]
Common Name English
SEROTONIN [MART.]
Common Name English
3-(.BETA.-AMINOETHYL)-5-HYDROXYINDOLE
Systematic Name English
Classification Tree Code System Code
LOINC 14910-4
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
NCI_THESAURUS C687
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 2939-7
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
DSLD 4216 (Number of products:1)
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 42671-8
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 32339-4
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 25524-0
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 34373-1
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 34374-9
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 25981-2
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 17003-5
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 2940-5
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 18375-6
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 2941-3
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 71804-9
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 18253-5
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 56978-0
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 26035-6
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
LOINC 27057-9
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
Code System Code Type Description
PUBCHEM
5202
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
WIKIPEDIA
SEROTONIN
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
SMS_ID
100000078432
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
CHEBI
350546
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
NCI_THESAURUS
C828
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
MERCK INDEX
m9871
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY Merck Index
ECHA (EC/EINECS)
200-058-9
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
MESH
D012701
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
CHEBI
28790
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
CAS
50-67-9
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
RXCUI
1311214
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY RxNorm
EPA CompTox
DTXSID8075330
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
DRUG BANK
DB08839
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
FDA UNII
333DO1RDJY
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
DAILYMED
333DO1RDJY
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
EVMPD
SUB15230MIG
Created by admin on Mon Mar 31 17:52:43 GMT 2025 , Edited by admin on Mon Mar 31 17:52:43 GMT 2025
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Natural agonist
IC50
TARGET -> AGONIST
Natural agonist
TRANSPORTER -> SUBSTRATE
TARGET -> AGONIST
TARGET -> AGONIST
BINDING
Ki
TARGET -> AGONIST
Natural agonist
BINDING
IC50
TARGET -> AGONIST
Natural agonist
BINDING
IC50
TARGET -> SUBSTRATE
BINDING
IC50
SALT/SOLVATE -> PARENT
ACTIVATOR OF RELEASE->TARGET
SALT/SOLVATE -> PARENT
TARGET -> AGONIST
BINDING
Ki
TARGET -> AGONIST
Stimulation of IP-1 formation
ASSAY (Functional)
EC50
TARGET -> AGONIST
Natural agonist
Ki
TRANSPORTER -> SUBSTRATE
Ki
SALT/SOLVATE -> PARENT
Related Record Type Details
METABOLITE -> PARENT
METABOLITE -> PARENT
METABOLITE -> PARENT
PARENT -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY